New Study Investigates COVID Vaccine in Rheumatoid Arthritis, Scleroderma, Myositis, and Sjogren’s Syndrome Patients

September 23, 2021

The University of Pittsburgh Medical Center is recruiting participants for a new study investigating the immune response to the COVID-19 vaccine in those living with autoimmune disease, including rheumatoid arthritis, scleroderma, myositis, and Sjogren’s syndrome.

Autoimmune disease patients were not included in original COVID-19 vaccine clinical trials, and there is “little information regarding the COVID-19 vaccine’s effectiveness and overall safety for patients with autoimmune diseases.” The study will measure antibody levels against SARS-CoV-2, and track whether vaccination leads to disease flares, changes in symptoms, or adverse effects.

To learn more about the study, as well as information on participating, click here.





Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.